Investor login
  • Home
  • About us
    • Team
    • Corporate Governance
    • Awards
    • Join us
      • Current Opportunities
      • Intern Programme
  • How to invest
  • Seeking capital
    • Investment Criteria
    • Review Process & Confidentiality
    • Useful Links
    • Submit a Business Plan
  • Portfolio
  • News & events
    • Our news
    • Portfolio news
    • Events
  • Contact
    • Request information
Oxford Capital Partners

Oxford Capital Partners News

15 December 2006: TXT4, investment in SMS advertising response technology
06 December 2006: Orthomimetics, new investment in orthopaedic medical device technology
24 November 2006: Oxford Capital Partners launches its fourth Venture Capital Fund
30 October 2006: Concurrent Thinking, new investment in high performance computing systems
13 October 2006: Helveta, investment in timber tracking technology
21 September 2006: David Mott named Venture Capital Young Personality of the Year
28 July 2006: Application Developments, investment in innovative stock, asset and security management software
22 May 2006: Sphere Medical, investment in novel patient care technologies
09 May 2006: Private Equity Awards of the BVCA & Real Deals recognise Oxford Capital Partners’ contribution to the Venture Capital Sector
13 April 2006: Inetec, investment in waste-to-renewable-energy technology
23 March 2006: TXT4, investment in SMS advertising response technology
20 March 2006: Oxford Capital Partners shortlisted as House of the Year at BVCA Real Deals Private Equity Awards
16 March 2006: Oxford Capital Partners mentors the heroes of tomorrow
15 February 2006: Oxford Capital Partners joins the European Venture Capital Association
20 January 2006: Oxford Capital Partners Benefits from 3 IPOs in 2005
06 January 2006: Oxford Capital Partners completes 12 investments in 2005

Oxford Capital Partners News Archives by year:
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004

Latest Portfolio News

  • TiGenix announces spin-out drug discovery - Arcarios
  • Scancell Sign Antibody Licence Agreement with Cancer Research Technology
  • Sphere Medical clinical trial proves technology works in hospital patients

All Portfolio News...

GET IN TOUCH

Please call us on 01865 860 760

or send an email to info@oxcp.com

or Request information from Oxford Capital Partners.

Make font smallerMake font larger[ print this page ]

Authorised and Regulated by the Financial Services Authority© 1999 - 2010 Oxford Capital Partners Limited. All Rights Reserved | Terms of use

Authorised and Regulated by the Financial Services Authority

Member of BVCA and EVCA

Website by commun